Point-of-Care Ultraviolet Microscopy for Cervical Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

September 30, 2024

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

Ultraviolet Microscopic Analysis

"Data to be collected from subjects at the time of their clinical visit; or upon chart review by the research team; will include demographic information, whether the subject is presenting for a routine screen or for a follow-up, and the subject's most recent cervical cytology result. Data to be collected from the standard-of-care cytology will include the cytologic diagnosis and the presence or absence of human papilloma virus (HPV), if applicable based on the subject's age. The Pap results of each subject will be reviewed and classified as screen negative (NIL), screen positive (LSIL, HSIL), or indeterminate (ASCUS, ASC-H). Subjects with a positive screen, or an indeterminate result, who undergo colposcopy will have their colposcopy results recorded as well. The UV microscopy imaging features will be coded and collected."

Trial Locations (1)

85719

Banner University Medical Center, Tucson

All Listed Sponsors
lead

University of Arizona

OTHER

NCT05899647 - Point-of-Care Ultraviolet Microscopy for Cervical Cancer Screening | Biotech Hunter | Biotech Hunter